 
    The Waters Corporation (WAT) provides analytical workflow solutions globally. It has a strong market presence in the healthcare sector, specializing in diagnostics and research. The stock is currently under analyst focus due to its innovative product solutions in high-performance instrumentation.
Waters Corporation has been assigned a fundamental rating of B+. The scores offer insight into the company's valuation metrics, including discounted cash flow, return on equity, and debt to equity ratio.
| Category | Score | Visual | 
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 1 | 
A comparison of historical ratings offers insights into the company's consistent performance over time.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B | 
|---|---|---|---|---|---|---|---|
| 2025-07-03 | 3 | 4 | 5 | 5 | 1 | 2 | 1 | 
| NA | 0 | 4 | 5 | 5 | 1 | 2 | 1 | 
The analyst price targets provide insights into the expected market performance of the stock.
| High | Low | Median | Consensus | 
|---|---|---|---|
| 400 | 374 | 387 | 387 | 
 
Analyzing analyst recommendations provides a look into market sentiment towards the stock.
| Recommendation | Count | Visual | 
|---|---|---|
| Strong Buy | 0 | |
| Buy | 10 | |
| Hold | 19 | |
| Sell | 3 | |
| Strong Sell | 0 | 
Waters Corporation has a strong position in the healthcare diagnostics and research sector, with solid fundamental ratings and consistent scores over time. Analyst sentiment suggests a 'Hold' consensus due to balanced buy and hold positions. Challenges include a moderate debt-to-equity ratio. Investors should consider these factors alongside the industry's growth potential.